Retatrutide outperforms Tirzepatide in clinical weight loss trials, delivering 24.2% average weight loss compared to Tirzepatides 20.9% at maximum doses
Others explore alternating between semaglutide and tirzepatide as a strategy for overcoming resistance
The answer is that cagrilintide is the harder peptide of the two to make
Pignatelli, P., Tellan, G., Marandola, M., Carnevale, R., Loffredo, L., Schillizzi, M., Proietti, M., Violi, F., Chirletti, P., and Delogu, G
Users should be aware of several potential side effects linked to hydration and kidney function: Decreased urine output : Dehydration from gastrointestinal side effects can lead to less frequent urination